Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 3Completed 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Hodgkin Disease 29Lymphoma 27HIV Infections 11Acquired Immunodeficiency Syndrome 10Testicular Neoplasms 9Teratoma 8Lymphoma, Non-Hodgkin 8Testicular Germ Cell Tumor 6Sarcoma, Kaposi 6Lymphoma, Follicular 6Endodermal Sinus Tumor 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Embryonal 5Head and Neck Neoplasms 4Seminoma 3Neoplasm Metastasis 3Teratoma, Testicular 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Germ Cell Cancer 2Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Cardiotoxicity 2Burkitt Lymphoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Skin Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Bleomycin × Clear all
NCT00198263 2017-10-03

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

Inovio Pharmaceuticals

Phase 4 Completed
95 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT00198276 2017-10-03

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

Inovio Pharmaceuticals

Phase 4 Completed
88 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡